Year archive

NurExone Biologic Inc — 2023 filings

All 46 regulatory filings released by NurExone Biologic Inc (NRX) in 2023, sourced directly from the official regulator.

46 Filings

2023 Period

2023 filings (46)

Filing	Released	Lang
News release - English.pdf Interim / Quarterly Report	2023-11-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-11-24	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-11-24	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-11-24	English
Material change report - English.pdf Regulatory Filings	2023-11-09	English
News release - English.pdf Regulatory Filings	2023-10-19	English
News release - English.pdf Capital/Financing Update	2023-10-11	English
News release - English.pdf Regulatory Filings	2023-10-05	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2023-09-18	English
Material change report - English.pdf Capital/Financing Update	2023-09-18	English
News release - English.pdf Capital/Financing Update	2023-09-06	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2023-09-05	English
Material change report - English.pdf Capital/Financing Update	2023-09-05	English
News release - English.pdf Regulatory Filings	2023-07-20	English
Material change report - English.pdf Board/Management Information	2023-07-17	English
News release - English.pdf Board/Management Information	2023-07-07	English
News release - English.pdf Regulatory Filings	2023-06-22	English
News release - English.pdf Regulatory Filings	2023-06-01	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2023-05-29	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2023-05-29	English
Notice of meeting - English.pdf AGM Information	2023-05-29	English
Interim financial statements/report – English.pdf Regulatory Filings	2023-05-24	English
News release - English.pdf Interim / Quarterly Report	2023-05-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-05-24	English
News release - English.pdf Capital/Financing Update	2023-05-12	English
News release - English.pdf Board/Management Information	2023-05-08	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2023-04-21	English
News release - English.pdf Annual Report	2023-03-30	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2023-03-30	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2023-03-30	English
Annual information form - English.pdf Regulatory Filings	2023-03-30	English
Material document(s).pdf Regulatory Filings	2023-03-30	English
Material document(s).pdf Regulatory Filings	2023-03-30	English
Material document(s).pdf Regulatory Filings	2023-03-30	English
Material document(s).pdf Regulatory Filings	2023-03-30	English
Material document(s).pdf Legal Proceedings Report	2023-03-30	English
Material document(s).pdf Regulatory Filings	2023-03-30	English
Annual MD&A - English.pdf Management Reports	2023-03-30	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2023-03-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2023-03-30	English
Audited annual financial statements – English.pdf Annual Report	2023-03-30	English
News release - English.pdf Regulatory Filings	2023-03-21	English
News release - English.pdf Regulatory Filings	2023-03-21	English
News release - English.pdf Investor Presentation	2023-03-21	English
Material change report - English.pdf Regulatory Filings	2023-01-23	English
News release - English.pdf Regulatory Filings	2023-01-12	English